Form 4: Quest Diagnostics Officer Sells Shares for Tax Obligations
Insider Transaction Report
Mark E. Delaney, SVP & Chief Commercial Officer at Quest Diagnostics, sold 188 shares of common stock to cover tax obligations from restricted share unit vesting.
Summary
- Mark E. Delaney, SVP & Chief Commercial Officer of Quest Diagnostics Inc. (DGX), disposed of 188 shares of common stock.
- The transaction occurred on March 2, 2026, at a price of $204.86 per share.
- The sale was executed to satisfy tax obligations resulting from the vesting of previously granted restricted share units.
- Following this transaction, Mr. Delaney beneficially owns 8,508 shares of Quest Diagnostics common stock.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event. The transaction is a routine sale to cover tax liabilities associated with equity compensation, which is a common practice and does not indicate a change in company fundamentals or insider sentiment.
Industry Context
StockSavvy.ai notes that insider sales to cover tax obligations upon the vesting of restricted stock units are a common and routine occurrence across all industries, including the diagnostic services sector. This type of transaction typically does not reflect a change in management's outlook on the company's fundamentals or future prospects.
Stakeholder Impact
- Minimal direct impact on shareholders as this is a small, routine transaction by an executive to cover tax obligations, not a discretionary sale indicating a lack of confidence.
Key Dates
| Date | Description |
|---|---|
| 03/02/2026 | Date of transaction for the sale of common stock. |
| 03/04/2026 | Date the Form 4 was signed by the reporting person's attorney-in-fact. |
Recommendation
holdThis Form 4 reports a routine, non-discretionary sale of a small number of shares by an executive to cover tax obligations arising from the vesting of restricted stock units. Such transactions are common and do not typically signal a change in the company's fundamentals or the executive's long-term view. Therefore, it provides no new information to warrant a change in investment recommendation, suggesting a 'hold' position for existing investors.
Keywords
Quest Diagnostics, DGX, Mark E. Delaney, Insider Transaction, Form 4, Common Stock, Tax Obligation, Restricted Share Units
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.